Paul Bröckelmann: Gaining insights into the biology of Hodgkin lymphoma
Paul Bröckelmann, Physician Scientist at MPI for Biology of Ageing, reshared a post on X by Raul Cordoba Mascuñano, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, Madrid, adding:
“Thanks for the shout-out and support, Raul Cordoba Mascuñano.
Grateful to the European Hematology Association for the opportunity to strengthen European collaboration and gain further insights into the biology of Hodgkin lymphoma in older patients to explore novel therapeutic approaches.”
Quoting Raul Cordoba Mascuñano’s post:
“Kudos to Dr. Paul Bröckelmann, University of Cologne, Department of Internal Medicine, Hematology.
The European Hematology Association and SWG Committee has selected his application for the SWG-Initiated Research Grants involving the SWG Aging and Hematology.”
Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023